| Stem definition | Drug id | CAS RN |
|---|---|---|
| radiopharmaceuticals, iodine-contained | 4296 | 7681-11-0 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed)
|
| Dose | Unit | Route |
|---|---|---|
| 1.20 | g | O |
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Nov. 9, 1979 | FDA | MEDPOINTE PHARM HLC |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Hyperthyroidism | 38.71 | 20.47 | 16 | 2336 | 14657 | 63472013 |
| Hypokalaemia | 23.88 | 20.47 | 24 | 2328 | 103780 | 63382890 |
| Obstructive pancreatitis | 23.85 | 20.47 | 5 | 2347 | 418 | 63486252 |
| General physical health deterioration | 23.67 | 20.47 | 33 | 2319 | 201369 | 63285301 |
| Anuria | 21.17 | 20.47 | 10 | 2342 | 12541 | 63474129 |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Toxic epidermal necrolysis | 45.76 | 27.29 | 18 | 858 | 21628 | 34934427 |
| Regurgitation | 39.27 | 27.29 | 9 | 867 | 1690 | 34954365 |
| Oropharyngeal discomfort | 33.62 | 27.29 | 9 | 867 | 3187 | 34952868 |
| Vitamin B12 deficiency | 31.55 | 27.29 | 9 | 867 | 4022 | 34952033 |
| Eructation | 30.13 | 27.29 | 9 | 867 | 4722 | 34951333 |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Hyperthyroidism | 39.22 | 20.61 | 17 | 2314 | 22192 | 79719865 |
| General physical health deterioration | 35.70 | 20.61 | 42 | 2289 | 275196 | 79466861 |
| Regurgitation | 33.44 | 20.61 | 9 | 2322 | 2778 | 79739279 |
| Toxic epidermal necrolysis | 30.62 | 20.61 | 18 | 2313 | 44563 | 79697494 |
| Vitamin B12 deficiency | 28.79 | 20.61 | 10 | 2321 | 7231 | 79734826 |
| Hypokalaemia | 25.65 | 20.61 | 26 | 2305 | 144014 | 79598043 |
| Oropharyngeal discomfort | 25.07 | 20.61 | 9 | 2322 | 7157 | 79734900 |
| Eructation | 24.79 | 20.61 | 10 | 2321 | 10899 | 79731158 |
| Thyrotoxic crisis | 24.49 | 20.61 | 6 | 2325 | 1278 | 79740779 |
None
| Source | Code | Description |
|---|---|---|
| ATC | R05CA02 | RESPIRATORY SYSTEM COUGH AND COLD PREPARATIONS EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS Expectorants |
| ATC | S01XA04 | SENSORY ORGANS OPHTHALMOLOGICALS OTHER OPHTHALMOLOGICALS Other ophthalmologicals |
| ATC | V03AB21 | VARIOUS ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS Antidotes |
| CHEBI has role | CHEBI:48578 | free radical scavengers |
| CHEBI has role | CHEBI:77035 | expectorants |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Cough | indication | 49727002 | |
| Allergic rhinitis | indication | 61582004 | |
| Nasal discharge | indication | 64531003 | |
| Nasal congestion | indication | 68235000 | |
| Common cold | indication | 82272006 | DOID:10459 |
| Thyroid Gland Radiation Protection | indication | ||
| Neonatal thyrotoxicosis | off-label use | 13795004 | DOID:12573 |
| Lymphocutaneous sporotrichosis | off-label use | 87603003 | |
| Thyroid Surgery | off-label use | ||
| Goiter | contraindication | 3716002 | DOID:12176 |
| Tachyarrhythmia | contraindication | 6285003 | |
| Suicidal thoughts | contraindication | 6471006 | |
| Dependent drug abuse | contraindication | 6525002 | |
| Alcoholism | contraindication | 7200002 | |
| Hyperammonemia | contraindication | 9360008 | |
| Peptic ulcer | contraindication | 13200003 | DOID:750 |
| Chronic obstructive lung disease | contraindication | 13645005 | DOID:3083 |
| Hepatic encephalopathy | contraindication | 13920009 | DOID:13413 |
| Hyperkalemia | contraindication | 14140009 | |
| Chronic disease of respiratory system | contraindication | 17097001 | |
| Mood swings | contraindication | 18963009 | |
| Pulmonary edema | contraindication | 19242006 | DOID:11396 |
| Hashimoto thyroiditis | contraindication | 21983002 | |
| Myocardial infarction | contraindication | 22298006 | DOID:5844 |
| Inflammatory bowel disease | contraindication | 24526004 | DOID:0050589 |
| Ventricular tachycardia | contraindication | 25569003 | |
| Acute tuberculosis | contraindication | 25629007 | |
| Shock | contraindication | 27942005 | |
| Bronchitis | contraindication | 32398004 | DOID:6132 |
| Hyperthyroidism | contraindication | 34486009 | DOID:7998 |
| Depressive disorder | contraindication | 35489007 | |
| Acute hepatitis | contraindication | 37871000 | |
| Hypertensive disorder | contraindication | 38341003 | DOID:10763 |
| Disorder of gallbladder | contraindication | 39621005 | DOID:0060262 |
| Hypothyroidism | contraindication | 40930008 | DOID:1459 |
| Third trimester pregnancy | contraindication | 41587001 | |
| Conduction disorder of the heart | contraindication | 44808001 | |
| Low blood pressure | contraindication | 45007003 | |
| Chronic heart failure | contraindication | 48447003 | |
| Bradycardia | contraindication | 48867003 | |
| Disorder of cardiovascular system | contraindication | 49601007 | DOID:1287 |
| Acidosis | contraindication | 51387008 | |
| Multiple organ failure | contraindication | 57653000 | |
| Hepatic failure | contraindication | 59927004 | |
| Poisoning by phenobarbital | contraindication | 64921004 | |
| Arterial thrombosis | contraindication | 65198009 | |
| Drug AND/OR toxin-induced diarrhea | contraindication | 65979008 | |
| Substance abuse | contraindication | 66214007 | |
| Benign intracranial hypertension | contraindication | 68267002 | DOID:11459 |
| Psychotic disorder | contraindication | 69322001 | |
| Arteriosclerotic vascular disease | contraindication | 72092001 | |
| Hepatic coma | contraindication | 72836002 | DOID:12550 |
| Diabetes mellitus | contraindication | 73211009 | DOID:9351 |
| Sleep apnea | contraindication | 73430006 | DOID:0050847 |
| Urethral stricture | contraindication | 76618002 | |
| Decreased respiratory function | contraindication | 80954004 | |
| Injury of head | contraindication | 82271004 | |
| Chronic idiopathic constipation | contraindication | 82934008 | |
| Cor pulmonale | contraindication | 83291003 | DOID:8515 |
| Epilepsy | contraindication | 84757009 | DOID:1826 |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Dermatitis herpetiformis | contraindication | 111196000 | DOID:8505 |
| Acute abdominal pain | contraindication | 116290004 | |
| Procedure on urinary system | contraindication | 118677009 | |
| Gastrointestinal obstruction | contraindication | 126765001 | |
| Seizure disorder | contraindication | 128613002 | |
| Cystic fibrosis | contraindication | 190905008 | DOID:1485 |
| Angina pectoris | contraindication | 194828000 | |
| Partial atrioventricular block | contraindication | 195039008 | |
| Acute pancreatitis | contraindication | 197456007 | DOID:2913 |
| Disease of liver | contraindication | 235856003 | DOID:409 |
| Bladder outflow obstruction | contraindication | 236645006 | |
| Sepsis syndrome | contraindication | 238150007 | |
| Hypocomplementemic urticarial vasculitis | contraindication | 239945009 | |
| Benign prostatic hyperplasia | contraindication | 266569009 | |
| Dyspnea | contraindication | 267036007 | |
| Retention of urine | contraindication | 267064002 | |
| Anemia | contraindication | 271737000 | DOID:2355 |
| Continuous fever | contraindication | 271751000 | |
| Pregnancy, function | contraindication | 289908002 | |
| Lesion of brain | contraindication | 301766008 | |
| Thrombocytopenic disorder | contraindication | 302215000 | DOID:1588 |
| Neutropenic disorder | contraindication | 303011007 | DOID:1227 |
| Primary adrenocortical insufficiency | contraindication | 373662000 | |
| Smoking cessation assistance | contraindication | 384742004 | |
| Operation on gastrointestinal tract | contraindication | 386621005 | |
| Hypoxia | contraindication | 389086002 | |
| Angle-closure glaucoma | contraindication | 392291006 | DOID:13550 |
| Pseudomembranous enterocolitis | contraindication | 397683000 | |
| Breastfeeding (mother) | contraindication | 413712001 | |
| Chronic myocardial ischemia | contraindication | 413844008 | DOID:3393 |
| Disorder of coronary artery | contraindication | 414024009 | |
| Myocardial ischemia | contraindication | 414795007 | DOID:3393 |
| Central nervous system depression | contraindication | 418072004 | |
| Porphyria | contraindication | 418470004 | |
| Ultrarapid metabolizer due to cytochrome p450 CYP2D6 variant | contraindication | 422681000 | |
| Dysfunction of sphincter of Oddi | contraindication | 430887001 | |
| Hypertensive urgency | contraindication | 443482000 | |
| Smokes tobacco daily | contraindication | 449868002 | |
| Acute exacerbation of asthma | contraindication | 708038006 | |
| Severe Hypoxemia | contraindication | ||
| Theophylline Toxicity | contraindication |
None
None
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Carbonic anhydrase 4 | Enzyme | Ki | 4.10 | CHEMBL |
| ID | Source |
|---|---|
| 4017676 | VUID |
| N0000146052 | NUI |
| D01016 | KEGG_DRUG |
| 4017645 | VANDF |
| 4017676 | VANDF |
| C0032831 | UMLSCUI |
| CHEBI:8346 | CHEBI |
| CHEMBL1141 | ChEMBL_ID |
| D011193 | MESH_DESCRIPTOR_UI |
| DB06715 | DRUGBANK_ID |
| 1C4QK22F9J | UNII |
| 4875 | PUBCHEM_CID |
| 8597 | RXNORM |
| 1847 | MMSL |
| 5333 | MMSL |
| d00800 | MMSL |
| 000734 | NDDF |
| 000846 | NDDF |
| 003151 | NDDF |
| 007600 | NDDF |
| 400389005 | SNOMEDCT_US |
| 89351005 | SNOMEDCT_US |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| POTASSIUM IODIDE | HUMAN OTC DRUG LABEL | 1 | 0178-0314 | SOLUTION | 65 mg | ORAL | ANDA | 17 sections |
| POTASSIUM IODIDE | HUMAN OTC DRUG LABEL | 1 | 0178-0314 | SOLUTION | 65 mg | ORAL | ANDA | 17 sections |
| CitraNatal 90 DHA | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0178-0821 | TABLET | 150 ug | ORAL | unapproved drug other | 11 sections |
| CitraNatal 90 DHA | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0178-0821 | TABLET | 150 ug | ORAL | unapproved drug other | 11 sections |
| CitraNatal Rx | HUMAN PRESCRIPTION DRUG LABEL | 13 | 0178-0858 | TABLET | 150 mg | ORAL | Unapproved drug other | 12 sections |
| CitraNatal Rx | HUMAN PRESCRIPTION DRUG LABEL | 14 | 0178-0859 | TABLET | 150 mg | ORAL | Unapproved drug other | 9 sections |
| CitraNatal DHA | HUMAN OTC DRUG LABEL | 14 | 0178-0898 | TABLET | 150 mg | ORAL | Unapproved drug other | 11 sections |
| ThyroShield | HUMAN OTC DRUG LABEL | 1 | 0256-0210 | SOLUTION | 65 mg | ORAL | ANDA | 24 sections |
| Humco Strong Iodine | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0395-2775 | LIQUID | 100 mg | ORAL | unapproved drug other | 12 sections |
| Humco Strong Iodine | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0395-2775 | LIQUID | 100 mg | ORAL | unapproved drug other | 12 sections |
| Vitafol Ultra | HUMAN PRESCRIPTION DRUG LABEL | 17 | 0642-0093 | CAPSULE, LIQUID FILLED | 150 ug | ORAL | UNAPPROVED DRUG OTHER | 13 sections |
| Vitafol Ultra | HUMAN PRESCRIPTION DRUG LABEL | 17 | 0642-0093 | CAPSULE, LIQUID FILLED | 150 ug | ORAL | UNAPPROVED DRUG OTHER | 13 sections |
| Vitafol Fe Plus | HUMAN PRESCRIPTION DRUG LABEL | 17 | 0642-7473 | CAPSULE, LIQUID FILLED | 150 ug | ORAL | UNAPPROVED DRUG OTHER | 14 sections |
| Vitafol Fe Plus | HUMAN PRESCRIPTION DRUG LABEL | 17 | 0642-7473 | CAPSULE, LIQUID FILLED | 150 ug | ORAL | UNAPPROVED DRUG OTHER | 14 sections |
| TriStart DHA | HUMAN PRESCRIPTION DRUG LABEL | 15 | 15370-250 | CAPSULE, LIQUID FILLED | 200 ug | ORAL | UNAPPROVED DRUG OTHER | 12 sections |
| Potassium Iodide | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16477-601 | SOLUTION | 1 g | ORAL | unapproved drug other | 18 sections |
| IODINE | HUMAN OTC DRUG LABEL | 2 | 16638-166 | SOLUTION | 0.20 g | TOPICAL | OTC monograph not final | 9 sections |
| SSKI | HUMAN PRESCRIPTION DRUG LABEL | 1 | 17856-0114 | SOLUTION | 1 g | ORAL | UNAPPROVED DRUG OTHER | 18 sections |
| SSKI | HUMAN PRESCRIPTION DRUG LABEL | 1 | 17856-0114 | SOLUTION | 1 g | ORAL | UNAPPROVED DRUG OTHER | 18 sections |
| PNV-Select | HUMAN PRESCRIPTION DRUG LABEL | 18 | 42192-320 | TABLET, FILM COATED | 150 ug | ORAL | unapproved drug other | 10 sections |
| PNV-Omega | HUMAN PRESCRIPTION DRUG LABEL | 13 | 42192-332 | CAPSULE, GELATIN COATED | 150 ug | ORAL | unapproved drug other | 12 sections |
| Strong Iodine Solution | HUMAN PRESCRIPTION DRUG LABEL | 2 | 48433-230 | SOLUTION/ DROPS | 1400 mg | ORAL | unapproved drug other | 11 sections |
| ThyroSafe | HUMAN OTC DRUG LABEL | 1 | 50633-910 | TABLET | 65 mg | ORAL | ANDA | 10 sections |
| NESTABSPrenatal Multi-vitamin/Mineral Supplement | HUMAN PRESCRIPTION DRUG LABEL | 15 | 50967-219 | TABLET, FILM COATED | 100 ug | ORAL | unapproved drug other | 8 sections |
| NESTABSPrenatal Multi-vitamin/Mineral Supplement | HUMAN PRESCRIPTION DRUG LABEL | 15 | 50967-219 | TABLET, FILM COATED | 100 ug | ORAL | unapproved drug other | 8 sections |
| IOSAT | HUMAN OTC DRUG LABEL | 1 | 51803-001 | TABLET | 130 mg | ORAL | NDA | 16 sections |
| IOSAT | HUMAN OTC DRUG LABEL | 1 | 51803-001 | TABLET | 130 mg | ORAL | NDA | 16 sections |
| IOSAT | HUMAN OTC DRUG LABEL | 1 | 51803-001 | TABLET | 130 mg | ORAL | NDA | 16 sections |
| IOSAT | HUMAN OTC DRUG LABEL | 1 | 51803-002 | TABLET | 65 mg | ORAL | NDA | 16 sections |
| IOSAT | HUMAN OTC DRUG LABEL | 1 | 51803-002 | TABLET | 65 mg | ORAL | NDA | 16 sections |